Summary
Overview
Work History
Education
Skills
References
Timeline
Robert J. Maguire

Robert J. Maguire

East Lyme,CT

Summary

Dynamic, independent and experienced director of medicinal chemistry seeking a role leveraging a broad skill set to accelerate novel asset delivery to IND and early phase development. Adept at collaborating with external resources and consultant support to complete projects in a thorough, cost-effective and timely manner.

Overview

21
21
years of professional experience

Work History

Director of Chemistry, Peptide Drug Conjugates

Cybrexa Therapeutics
10.2019 - Current
  • Responsible for all chemistry activities from lead discovery, medicinal chemistry, candidate nomination and clinical supply for Cybrexa’s peptide drug conjugates (PDC) assets
  • CBX-12: Led 3-person chemistry team to 261g of cGMP CBX-12 for IND from 50mg using external sourcing peptide, linker and exatecan conjugation (8 GMP steps), and DP production in phase appropriate manner
  • CBX-12: Completed design and sourcing >8000 lyophilized solid DP vial to support IND and FIH through Phase 2 clinical trials
  • CBX-12: Completed multi-kilo batches of CBX-12 peptide, linker and payload at CRO to support ~3.5kg CBX-12 for Ph2+ clinical trials and commercial development activity
  • CBX-12: Drove custom cGMP exatecan costs down from ~$1.2M/kg to $303K/kg through vendor selection/management
  • CBX12: Designed and sourced a novel, scalable stereoselective synthesis of proprietary linker that eliminated all chromatography
  • CBX12: Developed and sourced synthesis of double tritium labeled exatecan for developmental PK radiolabeling studies
  • CBX15: Designed and oversaw discovery chemistry program for MMAE-based PDC. Identified CBX15-51E as clinical development candidate.
  • CBX13: Designed new linkers and novel maytansine analogs to modulate the potency and release profile of Cybrexa’s DM4-based PDCs for lead development
  • External Resource: Managed collaborations and projects with over 30 external CROs, consultancy and CDMOs to execute Cybrexa chemistry’s discovery and scale-up activities
  • Supervision: Supervised development of master’s level chemist from lab-based role to independent external chemistry lead managing external medicinal chemistry for CBX13 and CBX15
  • Community: Supported Junior Achievement of Southeast Connecticut for career talks and mock interviewing of high school students

Founding Partner/Scientific Consultant

Thames Pharma Partners LLC
06.2019 - 10.2019

Director of Research and Development

Nalas Engineering Services
07.2018 - 12.2018

Senior Principal Scientist – Synthetic Technology Group

Pfizer Worldwide Medicinal Chemistry
06.2011 - 11.2018

Associate Research Fellow – Flow Chemistry/Applied Synthesis Technology

Pfizer Worldwide Medicinal Chemistry
11.2016 - 05.2018

Senior Principal Scientist – CVMED Reaction Optimization Group

Pfizer Worldwide Medicinal Chemistry
06.2009 - 06.2011

Senior Principal Scientist – CVMED Medicinal Chemistry

Pfizer Worldwide Medicinal Chemistry
06.2007 - 06.2009

Associate Director – Antibacterial, Immunology Cancer Lead Generation Group

Pfizer Worldwide Medicinal Chemistry
09.2003 - 06.2007

Education

Online Certificate - Project Management

School of Engineering, Cornell University, Ithaca, NY
09.2019

Post-Doctoral Research -

Université de Montréal, Montreal, QC
06.1997

Post-Doctoral Research -

Frei Universität-Berlin/J.W.Goethe-Universität, Frankfurt, Germany
05.1996

Ph. D - Synthetic Organic Chemistry

University of Manchester, Manchester, UK
12.1994

Skills

  • Medicinal Chemistry Design
  • External Analog and Library Synthesis
  • Route Optimization
  • Scientific Leadership
  • Project and Strategy Management
  • Creativity and Innovation
  • CRO and CDMO Management
  • Team Development
  • cGMP Scale Up
  • Project communication
  • Protein Drug Conjugate Design
  • CMC Management

References

References and publication list available on request.

Timeline

Director of Chemistry, Peptide Drug Conjugates - Cybrexa Therapeutics
10.2019 - Current
Founding Partner/Scientific Consultant - Thames Pharma Partners LLC
06.2019 - 10.2019
Director of Research and Development - Nalas Engineering Services
07.2018 - 12.2018
Associate Research Fellow – Flow Chemistry/Applied Synthesis Technology - Pfizer Worldwide Medicinal Chemistry
11.2016 - 05.2018
Senior Principal Scientist – Synthetic Technology Group - Pfizer Worldwide Medicinal Chemistry
06.2011 - 11.2018
Senior Principal Scientist – CVMED Reaction Optimization Group - Pfizer Worldwide Medicinal Chemistry
06.2009 - 06.2011
Senior Principal Scientist – CVMED Medicinal Chemistry - Pfizer Worldwide Medicinal Chemistry
06.2007 - 06.2009
Associate Director – Antibacterial, Immunology Cancer Lead Generation Group - Pfizer Worldwide Medicinal Chemistry
09.2003 - 06.2007
Université de Montréal - Post-Doctoral Research,
Frei Universität-Berlin/J.W.Goethe-Universität - Post-Doctoral Research,
University of Manchester - Ph. D, Synthetic Organic Chemistry
School of Engineering, Cornell University - Online Certificate, Project Management
Robert J. Maguire